Cisplatin-gemcitabine, vs. cisplatin-gemcitabine-vinorelbine, vs. cisplatin-gemcitabine-paclitaxel in advanced non-small-cell lung cancer. First-stage analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trialP. Comella, G. Comella, Adriano Gravina et al.|Lung Cancer|2000Cited by 16
231 Gemcitabine (GEM)-cisplatin (CDDP)-vinorelbine (VNR) combination in advanced non-small-cell lung cancer (NSCLC). A phase II randomized studyP. Comella, G. Comella, N. Panza et al.|Lung Cancer|1997Cited by 7
Treatment of Advanced Urothelial Carcinoma with M-VECA (Methotrexate, Vinblastine, Epirubicin and Carboplatin)Vito Lorusso, M. De Lena, Arcangelo Pagliarulo et al.|Journal of Chemotherapy|1996Cited by 5
Cisplatin — gemcitabine — paclitaxel (PGT) in the treatment of advanced non-small-cell lung cancer (NSCLC). A southern Italy cooperative oncology group (SICOG) phase II studyG. Frasci, G. Comella, P. Comella et al.|European Journal of Cancer|1999Cited by 3
Cisplatin-gemcitabine-vinorelbine (PGV) vs cisplatin-vinorelbine (PV) vs cisplatin-gemcitabine (PG) in advanced non-small cell lung cancer (NSCLC). Interim analysis of a SICOG phase III trialP. Comella, G. Comella, N. Panza et al.|European Journal of Cancer|1999Cited by 3